Catalyst Wire Dossier Catalyst Wire Dossier

Celecoxib (YM177)

celecoxib · Pfizer / Upjohn in merger with Mylan to form Viatris
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Celecoxib (YM177), covering 2012-11-19 to 2012-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain [Phase 2]

See pricing